This issue of the Journal of Cystic Fibrosis features the first in a series of three reviews focusing on CF microbiology. The article by Michael Parkins and Andres Floto examines changes in our perception of which bacterial species represent clinically important pathogens in the context of CF lung disease. These shifts have resulted from both technological advances that have improved detection and identification of potential pathogens, and from improvements in therapy that have changed disease course in CF patients.
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Pulmonary and Respiratory Medicine